Antithrombotic therapy: less is more or the more the better?

Europace. 2020 Jul 1;22(7):1142. doi: 10.1093/europace/euaa073.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Acute Coronary Syndrome* / drug therapy
  • Aspirin
  • Atrial Fibrillation* / diagnosis
  • Atrial Fibrillation* / drug therapy
  • Fibrinolytic Agents / adverse effects
  • Humans
  • Percutaneous Coronary Intervention*

Substances

  • Fibrinolytic Agents
  • Aspirin